Abstract
Artemisinin and its derivatives, since their discovery by professor Tu Youyou in the early 1970s, have been the bedrock for the management of malaria globally. Recent works have implied that they could be used to manage other diseases including neurodegenerative disorders. Neurodegenerative disorders mainly occur in the adult population resulting from a progressive deterioration of neuronal structures. These include Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and Multiple sclerosis (MS), among others. The PI3K/Akt signaling pathway plays a significant role in the central nervous system. It has been investigated extensively for its role in central nervous system physiological processes such as cell survival, autophagy, neuronal proliferation, and synaptic plasticity. Therefore, the modulation of this pathway will be crucial in the management of neurodegenerative disorders. This review seeks to compile most of the research findings on the possible neuroprotective role of artemisinins with special emphasis on their modulatory role on the PI3k/Akt pathway. A literature survey was conducted on PubMed, EBSCO, Web of Science, and EMBASE using the keyword artemisinins, and a total of 10,281 articles were retrieved from 1956 to 2022. Among these, 120 articles were examined using Mesh words like PI3k/Akt, neurodegeneration, and neuroinflammation coupled with boolean operators. Most research revealed that artemisinins could help neurodegenerative disorders by modulating the PI3k/Akt with subsequent inhibition of oxidative stress, neuroinflammation, and apoptosis. This paper illustrates that artemisinins could be repurposed as a neuroprotective agent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No data sets were analyzed or generated during this study.
References
Abdel Rasheed NO, Ibrahim WW (2022) Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington’s disease model in rats: cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway. Life Sci 297:120480. https://doi.org/10.1016/j.lfs.2022.120480
Armada-moreira A, Gomes JI, Pina CC, Savchak OK, Gonçalves-ribeiro J, Rei N, Pinto S, Crunelli V, Vaz SH (2020) Going the extra (synaptic ) mile : excitotoxicity as the road toward neurodegenerative diseases. 14(April):1–27. https://doi.org/10.3389/fncel.2020.00090
Armstrong R (2020) What causes neurodegenerative disease? Folia Neuropathol 58(2):93–112. https://doi.org/10.5114/FN.2020.96707
Bai X, Pei R, Lei W, Zhao M, Zhang J, Tian L, Shang J (2020) Antidiabetic effect of artemether in Db/Db mice involves regulation of AMPK and PI3K/Akt pathways. Front Endocrinol 11(September):1–9. https://doi.org/10.3389/fendo.2020.568864
Binh TQ, Ilett KF, Batty KT, Davis TME, Hung NC, Powell SM, Thu LTA, Van Thien H, Phuöng HL, Phuong VDB (2001) Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with Falciparum malaria. Br J Clin Pharmacol 51(6):541–546. https://doi.org/10.1046/j.1365-2125.2001.01395.x
Bonelli RM, Wenning GK, Kapfhammer HP (2004) Huntington’s disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol 19(2):51–62. https://doi.org/10.1097/00004850-200403000-00001
Borstnik K, Paik I, Posner G (2005) Malaria: new chemotherapeutic peroxide drugs. Mini-Rev Med Chem 2(6):573–583. https://doi.org/10.2174/1389557023405620
Chen S, Wu L, He B, Zhou G, Xu Y, Zhu G, Xie J, Chen S (2021) Artemisinin facilitates motor function recovery by enhancing motoneuronal survival and axonal remyelination in rats following brachial plexus root avulsion.https://doi.org/10.1021/acschemneuro.1c00120
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer’s disease. pp 329–352. https://doi.org/10.1007/978-94-007-5416-4_14
Dobson R, Giovannoni G (2019) Multiple sclerosis – a review. Eur J Neurol 26(1):27–40. https://doi.org/10.1111/ene.13819
Fan S, Zhang D, Liu F, Yang Y, Xu H (2020) Artesunate alleviates myocardial ischemia/reperfusion-induced myocardial necrosis in rats and hypoxia/reoxygenation-induced apoptosis in H9C2 cells via regulating the FAK/PI3K/Akt pathway. Ann Translat Med 8(20):1291–1291. https://doi.org/10.21037/atm-20-5182
Gao Y, Cui M, Zhong S, Feng C, Nwobodo AK, Chen B, Song Y, Wang Y (2020) Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K / AKT pathway. :661–672
Gautam A, Ahmed T, Paliwal J, Batra V (2009) Pharmacokinetics and Pharmacodynamics of endoperoxide antimalarials. Curr Drug Metab 10(3):289–306. https://doi.org/10.2174/138920009787846323
Guo F, Liu X, Cai H, Le W (2018) Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol 28(1):3–13. https://doi.org/10.1111/bpa.12545
Hauser SL, Cree BAC (2020) Treatment of multiple sclerosis : a review. Am J Med. https://doi.org/10.1016/j.amjmed.2020.05.049
Hemmings BA, Restuccia DF (2012) PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Med 4(9):1–4
Ho WE, Peh HY, Chan TK, Wong WSF (2014) Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142(1):126–139. https://doi.org/10.1016/j.pharmthera.2013.12.001
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (2018) Molecular pathogenesis in Huntington’s disease. Biochemistry (moscow) 83(9):1030–1039. https://doi.org/10.1134/S0006297918090043
Jabbarzadeh P, Salimian F, Aghapour S, Xiang S (2020) Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – a comprehensive review from chemotherapy to immunotherapy. 156(April). https://doi.org/10.1016/j.phrs.2020.104806
Jamwal S, Singh S, Kaur N, Kumar P (2015) Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism. Neurotox Res 28(2):171–184. https://doi.org/10.1007/s12640-015-9535-y
Jean S, Kiger AA (2014) Classes of phosphoinositide 3-kinases at a glance. :923–928. https://doi.org/10.1242/jcs.093773
Ji Y, Wang D, Zhang B, Lu H (2019) Bergenin ameliorates MPTP-induced Parkinson’s disease by activating PI3K/Akt signaling pathway. J Alzheim Dis. https://doi.org/10.3233/JAD-190870
Kim GH, Kim JE, Rhie SJ, Yoon S (2015) The role of oxidative stress in neurodegenerative diseases. 24(4):325–340.https://doi.org/10.5607/en.2015.24.4.325
Kiss E, Kins S, Zöller Y, Schilling S, Gorgas K, Groß D, Schlicksupp A, Rosner R, Kirsch J, Kuhse J (2021) Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model. Mol Cell Neurosci 113(June):1–5. https://doi.org/10.1016/j.mcn.2021.103624
Kovacs GG (2019) Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol 72(11):725–735. https://doi.org/10.1136/jclinpath-2019-205952
Kumar P, Kumar A (2009) Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington’s disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615(1–3):91–101. https://doi.org/10.1016/j.ejphar.2009.04.058
Lassmann H (2013) Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 333(1–2):1–4. https://doi.org/10.1016/j.jns.2013.05.010
Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133(7):1900–1913. https://doi.org/10.1093/brain/awq076
Li S, Zhao X, Lazarovici P, Zheng W (2019) Artemether Activation of AMPK/GSK3β(ser9)/Nrf2 Signaling Confers Neuroprotection towards β-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer’s Mouse Model. Oxid Med Cell Longev 1862437. https://doi.org/10.1155/2019/1862437
Lin SP, Li W, Winters A, Liu R, Yang SH (2018) Artemisinin prevents glutamate-induced neuronal cell death via Akt pathway activation. Front Cell Neurosci 12(April):1–9. https://doi.org/10.3389/fncel.2018.00108
Lin S, Wei J, Hu J, Bu J, Zhu L, Li Q, Liao H, Lin P, Ye S, Chen S, Chen X (2021) Artemisinin improves neurocognitive de fi cits associated with sepsis by activating the AMPK axis in microglia. September 2020. https://doi.org/10.1038/s41401-021-00634-3
Liu L, Zhao X, Silva M, Li S, Xing X, Zheng W (2020) Artemisinin protects motoneurons against axotomy-induced apoptosis through activation of the PKA-Akt signaling pathway and promotes neural stem/progenitor cells differentiation into NeuN + neurons. Pharmacol Res 159(April):105049. https://doi.org/10.1016/j.phrs.2020.105049
Liu Z, Ren Z, Zhang J, Chuang C (2018) Role of ROS and nutritional antioxidants in human diseases. 9(May):1–14.https://doi.org/10.3389/fphys.2018.00477
Liu Y, Dang W, Zhang S (2021) Artesunate attenuates inflammatory injury and inhibits the NF-k B pathway in a mouse model of cerebral ischemia.https://doi.org/10.1177/03000605211053549
Long H, Cheng Y, Zhou Z, Luo H, Wen D (2021) PI3K/AKT signal pathway : a target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. 12(April):1–20. https://doi.org/10.3389/fphar.2021.648636
Lu BW, Baum L, So KF, Chiu K, Xie LK (2019) More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration. Neural Regen Res 14(9):1494–1498. https://doi.org/10.4103/1673-5374.255960
Ma Z, Woon CY-N, Liu C-G, Cheng J-T, You M, Sethi G, Wong AL-A, Ho PC-L, Zhang D, Ong P, Wang L, Goh B-C (2021) Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge? Front Pharmacol 12(December):1–26. https://doi.org/10.3389/fphar.2021.828856
Manning BD, Toker A (2017) Review AKT/PKB signaling : navigating the network. Cell 169(3):381–405. https://doi.org/10.1016/j.cell.2017.04.001
Matsuda S, Ikeda Y, Murakami M, Nakagawa Y, Tsuji A, Kitagishi Y (2019) Roles of PI3K/AKT/GSK3 pathway involved in psychiatric illnesses. Diseases 7(1):22. https://doi.org/10.3390/diseases7010022
Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P (2000) Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39(4):255–270. https://doi.org/10.2165/00003088-200039040-00002
Newton PN, Van Vugt M, Teja-Isavadharm P, Siriyanonda D, Rasameesoroj M, Teerapong P, Ruangveerayuth R, Slight T, Nosten F, Suputtamongkol Y, Looareesuwan S, White NJ (2002) Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria. Antimicrob Agents Chemother 46(4):1125–1127. https://doi.org/10.1128/AAC.46.4.1125-1127.2002
Nitulescu GM, Margina D, Juzenas P, Peng Q, Spandidos DΑ, Libra M, Tsatsakis AM (2016) Akt inhibitors in cancer treatment : the long journey from drug discovery to clinical use (Review). 869–885. https://doi.org/10.3892/ijo.2015.3306
Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, Gao T, Wu P (2011) Critical role of PI3K/Akt/GSK3β in motoneuron specification from human neural stem cells in response to FGF2 and EGF. PLoS ONE 6(8):e23414. https://doi.org/10.1371/journal.pone.0023414
Okorji UP, Velagapudi R, El-Bakoush A, Fiebich BL, Olajide OA (2016) Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms. Mol Neurobiol 53(9):6426–6443. https://doi.org/10.1007/s12035-015-9543-1
Okorji UP, Velagapudi R, El-bakoush A (2015) Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms. https://doi.org/10.1007/s12035-015-9543-1
Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72(21 SUPPL 4). https://doi.org/10.1212/WNL.0b013e3181a1d44c
Peden AH, Ironside JW (2012) Molecular pathology in neurodegenerative diseases. Curr Drug Targets 13(12):1548–1559. https://doi.org/10.2174/138945012803530134
Peltier J, O’Neill A, Schaffer DV (2007) PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67(10):1348–1361. https://doi.org/10.1002/dneu.20506
Pinheiro LCS, Feitosa LM, da Silveira FF, Boechat N (2018) Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives. Anais Acad Bras Cienc 90(1):1251–1271. https://doi.org/10.1590/0001-3765201820170830
Pompura SL, Dominguez-Villar M (2018) The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol 103(6):1065–1076. https://doi.org/10.1002/JLB.2MIR0817-349R
Qin Y, Yang G, Li M, Liu HJ, Zhong WL, Yan XQ, Qiao KL, Yang JH, Zhai DH, Yang W, Chen S, Zhou HG, Sun T, Yang C (2017) Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt-snail pathway. Oncotarget 8(61):103815–103827. https://doi.org/10.18632/oncotarget.21793
Qin W, Cao L, Massey IY (2021) Role of PI3K/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem 476(11):4045–4059. https://doi.org/10.1007/s11010-021-04219-w
Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheim Dis 42:S125–S152. https://doi.org/10.3233/JAD-132738
Roberto M, Oliveira D, Costa G, Fernanda P (2016) Toxicology in vitro protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells : role for PI3K/Akt/Nrf2 pathway. TIV 32:41–54. https://doi.org/10.1016/j.tiv.2015.12.005
Rojas-quintero J, Rojas M, Bautista J, Martínez MS, Salazar J, Mendoza R, Bermúdez V (2017) iMedPub Journals excitotoxicity : an organized crime at the cellular level abstract the synapse : scene of the crime glutamate, receptors and calcium : the criminals glutamate : intellectual author. 8(3):1–10.https://doi.org/10.21767/2171-6625.1000193
Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, Caruso C (2021) Neuroinflammation in Huntington’s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol. https://doi.org/10.2174/1570159X19666211201094608
Salama RM, Abdel-Latif GA, Abbas SS, El Magdoub HM, Schaalan MF (2020) Neuroprotective effect of crocin against rotenone-induced Parkinson’s disease in rats: interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology 164:107900. https://doi.org/10.1016/j.neuropharm.2019.107900
Salińska E, Danysz W, Łazarewicz JW (2005) The role of excitotoxicity in neurodegeneration. Folia Neuropathol 43(4):322–329
Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S (2009) Progress in lipid research mammalian phosphoinositide kinases and phosphatases. Prog Lipid Res 48(6):307–343. https://doi.org/10.1016/j.plipres.2009.06.001
Sayed NH, Fathy N (2022) Vildagliptin attenuates Huntington’s disease through activation of GLP-1 receptor/PI3K/Akt/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 2020:252–268
Shao S, Wang GL, Raymond C, Deng XUEHUA, Zhu XLAN, Wang DI, Hong LEP (2017) Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson’s disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway. 1269–1277. https://doi.org/10.3892/mmr.2017.6751
Shi Z, Chen Y, Lu C, Dong LM, Lv JW, Tuo QH, Qin L, Cheng SW, Bu LL, Lin N, Zhu XX, Liao DF, Liu XM (2018) Resolving neuroinflammation, the therapeutic potential of the anti-malaria drug family of artemisinin. Pharmacol Res 136(September):172–180. https://doi.org/10.1016/j.phrs.2018.09.002
Shi C, Wu F, Yew DT (2010) Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells. 715–727. https://doi.org/10.1007/s10495-010-0492-x
Singh A, Kukreti R, Saso L (2019a) Oxidative stress : a key modulator in neurodegenerative diseases. Molecules 24(1583):1–20
Singh S, Dwivedi H, Gunjan S, Chauhan B (2019b) Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survival running title – understanding the role of arteether on NMDA receptor expression. Parasitology. https://doi.org/10.1017/S0031182019000878
Staal SP (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci 84(14):5034–5037. https://doi.org/10.1073/pnas.84.14.5034
Stephenson J, Nutma E, Van Der Valk P (2018) Inflammation in CNS neurodegenerative diseases. Immunology. https://doi.org/10.1111/imm.12922
Su XZ, Miller LH (2015) The discovery of artemisinin and the Nobel prize in physiology or medicine. Sci China Life Sci 58(11):1175–1179. https://doi.org/10.1007/s11427-015-4948-7
Subhramanyam CS, Wang C, Hu Q, Dheen ST (2019) Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol 94(January):112–120. https://doi.org/10.1016/j.semcdb.2019.05.004
Sugiyama MG, Fairn GD, Antonescu CN, Ceresa BP (2019) Akt-ing up just about everywhere : compartment-specific Akt activation and function in receptor tyrosine kinase signaling. 7(May):1–24. https://doi.org/10.3389/fcell.2019.00070
Sun X, Zhu J, Sun XY, Ji M, Yu XL, Liu RT (2020) Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington’s disease by lowering mutant huntingtin protein. Food Funct 11(2):1334–1348. https://doi.org/10.1039/c9fo02131k
Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Publ Group 15(1):7–24. https://doi.org/10.1038/nrc3860
Tu Y (2011) The discovery of artemisinin (Qinghaosu) and gifts from Chinese medicine. Nat Med 17(10):1217–1220. https://doi.org/10.1038/nm.2471
Tu Y (2016) Artemisinin—a gift from traditional Chinese medicine to the world (nobel lecture). Angew Chem Int Ed 55(35):10210–10226. https://doi.org/10.1002/anie.201601967
Wang A, Xiao C, Zheng J, Ye C, Dai Z, Wu Q, Liu J, Strappe P, Zhou Z (2020) Terpenoids of Ganoderma lucidum reverse cognitive impairment through attenuating neurodegeneration via suppression of PI3K/AKT/mTOR expression in vivo model. J Funct Foods 73(July):104142. https://doi.org/10.1016/j.jff.2020.104142
Wang P, Tian X, Tang J, Duan X, Wang J, Cao H, Qiu X, Wang W, Mai M, Yang Q, Liao R, Yan F (2021) Artemisinin protects endothelial function and vasodilation from oxidative damage via activation of PI3K/Akt/eNOS pathway. Exp Gerontol 147(December 2020):111270. https://doi.org/10.1016/j.exger.2021.111270
Weathers PJ, Elfawal MA, Towler MJ, Acquaah-Mensah GK, Rich SM (2014) Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice. J Ethnopharmacol 153(3):732–736. https://doi.org/10.1016/j.jep.2014.03.037
Wong YK, Xu C, Kalesh KA, He Y, Lin Q, Wong WSF, Shen HM, Wang J (2017) Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action. Med Res Rev 37(6):1492–1517. https://doi.org/10.1002/med.21446
Wyant KJ, Ridder AJ, Dayalu P (2017) Huntington’s disease—update on treatments. Curr Neurol Neurosci Rep 17(4). https://doi.org/10.1007/s11910-017-0739-9
Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, Jiang B, Feng J, Li J, Gu Y (2019) PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep 19(2):783–791. https://doi.org/10.3892/mmr.2018.9713
Xie J, Weiskirchen R (2020) What does the “AKT” stand for in the name “AKT Kinase”? Some historical comments. 10(August):1–2.https://doi.org/10.1091/mbc.2.12.1001
Xu YQ, Long L, Yan JQ, Wei L, Pan MQ, Gao HM, Zhou P, Liu M, Zhu CS, Tang BS, Wang Q (2013) Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses. CNS Neurosci Ther 19(3):170–177. https://doi.org/10.1111/cns.12053
Yan J, Ma H, Lai X, Wu J, Liu A, Huang J, Sun W, Shen M, Zhang Y (2021) Artemisinin attenuated oxidative stress and apoptosis by inhibiting autophagy in MPP+-treated SH-SY5Y cells. J Biol Res 28(1):1–10. https://doi.org/10.1186/s40709-021-00137-6
Yan F, Wang H, Gao Y, Xu J, Zheng W (2017) Artemisinin protects retinal neuronal cells against oxidative stress and restores rat retinal physiological function from light exposed damage. ACS Chem Neurosci 8(8):1713–1723. https://doi.org/10.1021/acschemneuro.7b00021
Yang D, Qiu J, Zhou H, Yu Y, Zhou D, Xu Y, Zhu M, Ge X, Li J, Lv C, Zhang H, Yuan W (2018) Dihydroartemisinin alleviates oxidative stress in bleomycin-induced pulmonary fibrosis. Life Sci. https://doi.org/10.1016/j.lfs.2018.05.022
Yoon JH, Lee N, Youn K, Jo MR, Kim HR, Lee DS, Ho CT, Jun M (2021) Dieckol ameliorates Aβ production via PI3K/Akt/GSK-3β regulated APP processing in SweAPP N2a cell. Mar Drugs 19(3). https://doi.org/10.3390/md19030152
Zeng Z, Xu J, Zheng W (2017) Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. https://doi.org/10.1016/j.redox.2017.04.003
Zhang E, Wang J, Chen Q, Wang Z, Li D, Jiang N, Ju X (2020a) Artesunate ameliorates sepsis-induced acute lung injury by activating the mTOR/AKT/PI3K axis. Gene 759(July):144969. https://doi.org/10.1016/j.gene.2020.144969
Zhang K, Yang Y, Ge H, Wang J, Chen X, Lei X, Zhong J, Zhang C, Xian J, Lu Y, Tan L, Feng H (2020) Artesunate promotes the proliferation of neural stem/progenitor cells and alleviates ischemia-reperfusion injury through PI3K/Akt/FOXO-3a/p27kip1 signaling pathway. Aging 12(9):8029–8048. https://doi.org/10.18632/aging.103121
Zhao X, Li S, Gaur U, Zheng W (2020) Artemisinin improved neuronal functions in Alzheimer’s disease animal model 3xtg mice and neuronal cells via stimulating the ERK/CREB signaling pathway. Aging Dis 11(4):801–819. https://doi.org/10.14336/AD.2019.0813
Zhao Y, Long Z, Ding Y, Jiang T, Liu J, Li Y, Liu Y, Peng X, Wang K, Feng M, He G (2020c) Dihydroartemisinin ameliorates learning and memory in Alzheimer’s disease through promoting autophagosome-lysosome fusion and autolysosomal degradation for Aβ clearance. Front Aging Neurosci 12(March):1–16. https://doi.org/10.3389/fnagi.2020.00047
Zhao X, Fang J, Li S, Gaur U, Xing X, Wang H, Zheng W (2019) Artemisinin attenuated hydrogen peroxide (H2O2)-induced oxidative injury in SH-SY5Y and hippocampal neurons via the activation of AMPK pathway. Int J Mol Sci 20(11). https://doi.org/10.3390/ijms20112680
Zhao X, Li S, Gaur U, Zheng W (2020b) Artemisinin improved neuronal functions in alzheimer's disease animal model 3xtg mice and neuronal cells via stimulating the ERK/CREB signaling pathway. Aging Dis 11(4):801–819. https://doi.org/10.14336/AD.2019.0813
Zheng W, Chong CM, Wang H, Zhou X, Zhang L, Wang R, Meng Q, Lazarovici P, Fang J (2016) Artemisinin conferred ERK mediated neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insult. Free Radical Biol Med 97(2):158–167. https://doi.org/10.1016/j.freeradbiomed.2016.05.023
Zhu C, Xiong Z, Chen X, Peng F, Hu X, Chen Y, Wang Q (2012) Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-k B pathway in microglia cells. 7(4):1–8.https://doi.org/10.1371/journal.pone.0035125
Acknowledgements
The authors are grateful to the Indian Council for Cultural Relation (ICCR) for their financial support to Mr. Richmond Arthur.
Author information
Authors and Affiliations
Contributions
RA and PK conceived and designed the research. RA wrote the draft manuscript, and PK and USN reviewed the final manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arthur, R., Navik, U. & Kumar, P. Repurposing artemisinins as neuroprotective agents: a focus on the PI3k/Akt signalling pathway. Naunyn-Schmiedeberg's Arch Pharmacol 396, 593–605 (2023). https://doi.org/10.1007/s00210-022-02350-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-022-02350-z